AHA Scientific Sessions 2022 Late-Breaking Science Coverage
Published: 02 November 2022
-
Views:
5307
-
Likes:
7
-
Views:
5307
-
Likes:
7
-
Up Next
-
8m 38sPart 3 | Session 4 PRECISION: Aprocitentan in the Treatment of Resistant Hypertension
-
9m 16s
-
5m
-
10m 6sPart 3 | Session 7 SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension
-
14m 20sPart 4 | Session 1 The PROMINENT Trial With Dr Kaur & Dr Pradhan
-
14m 28sPart 4 | Session 2 The OCEAN(a)-DOSE Trial With Dr Gurleen Kaur & Dr Michelle L O'Donoghue
-
18m 1sPart 4 | Session 3 The EMPA-Kidney Trial With Dr Wilcox & Dr Preiss
-
15m 37sPart 4 | Session 4 The PREVENT-HD Randomized Clinical Trial With Dr Fadah & Dr Piazza
-
14m 14sPart 4 | Session 5 The RESPECT EPA Trial With Prof Daida & Dr Jumkhawala
-
13m 6sPart 4 | Session 6 The PROGRESSIVE-AF Trial With Dr Wilcox & Dr Andrade
-
13m 45sPart 4 | Session 7 The ECMO-CS Trial With Dr Ostadal & Dr Jumkhawala
-
18m 58sPart 4 | Session 8 The IRONMAN Trial With Dr Amir & Dr Kalra
-
2m 9sPart 5 | Session 1 Being a Researcher With Investigator, Dr Julian Gillmore
-
56sPart 5 | Session 2 Research in 2022 With Investigator, Dr Shino Kany
-
3m 1sPart 5 | Session 3 Making a Difference With Physician-Scientist, Dr Schlaich
-
2m 51sPart 5 | Session 4 What Makes Dr Bonaca excited about CV Science in 2022?
-
5m 44sPart 6 | Session 1 Late-breaking Science Highlights With Dr Joseph A Hill
-
12m 38sPart 6 | Session 2 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag
-
35m 25sPart 1 | Session 1 What's Hot at AHA22? Late-Breaking Science Wrap-up Nicolas M Van Mieghem, Joost Daemen
-
15m 30sPart 1 | Session 2 What's Hot at AHA22? Late-Breaking Science Preview Nicolas M Van Mieghem, Joost Daemen
-
13m 29sPart 2 | Session 1 The TRANSFORM-HF Trial WIth Dr Van Spall & Dr Mentz Robert Mentz, Harriette Van Spall
-
21m 14sPart 2 | Session 2 The STRONG-HF Trial With Dr Van Spall & Prof Mebazaa Alexandre Mebazaa, Harriette Van Spall
-
14m 56sPart 2 | Session 3 The PRECISE Trial With Dr Van Spall & Dr Douglas Pamela S Douglas, Harriette Van Spall
-
8m 12sPart 3 | Session 1 CRISPR-Cas9 In Vivo Gene Editing in Pts With ATTR Amyloidosis With Cardiomyopathy Julian Gillmore
-
5m 39sPart 3 | Session 2 EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation Shino Kany
Overview
Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews.
With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View from the Thoraxcenter.
Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.
This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.
Look behind the scientific achievement and learn more about the personal motivations of some of the investigators, benefit from their advice for early career researchers through our Behind the Heart series.
More from this programme
Part 1
View from the Thoraxcenter: Review Series
Part 2
Late-breaker Discussions With Harriette Van Spall
Part 3
Expert Interviews
Part 4
Radcliffe & CardioNerds @AHA22
Part 5
Behind the Heart
Part 6
AHA22 Highlights
Faculty Biographies
![Marc P Bonaca](https://assets.radcliffecardiology.com/s3fs-public/author/2020-12/Marc.Bonaca.jpg)
Marc P Bonaca
Director of Vascular Research and an Associate Professor of Medicine
Dr Marc Bonaca is a Cardiologist and Vascular Medicine Specialist who serves as the Executive Director of CPC Clinical Research and CPC Community Health which is an Academic Research Organization created by and affiliated with the University of Colorado Anschutz Medical Campus. He is the Director of Vascular Research and an Associate Professor of Medicine at the University of Colorado School of Medicine and the inaugural holder of the William R. Hiatt Endowed Chair in Cardiovascular Research. CPC is a core resource of the University of Colorado research and community outreach infrastructure.
Dr Bonaca earned his medical degree from the University of Connecticut School of Medicine and his Masters in Public Health at Harvard University. He served as a Medical House Officer at Brigham and Women’s Hospital and Harvard Medical School. Following his medical residency training, he served as a Cardiology Fellow at Brigham and Women’s Hospital and subsequently completed a…